Apnea Sciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Apnea Sciences is a commercial-stage private company operating in the respiratory and medical device sectors, focused on non-invasive oral appliances for sleep-disordered breathing. Its core innovation lies in mandibular advancement devices (MADs), including the first FDA-cleared OTC anti-snoring mouthguard (SnoreRx) and a Class II medical device for mild-to-moderate sleep apnea (ApneaRx). The company targets the large and growing market of patients non-compliant with CPAP, positioning its products as cost-effective, clinically-proven alternatives. With a vertically integrated model from design to distribution, it serves both direct-to-consumer and healthcare provider channels.

Sleep ApneaSnoringBruxism

Technology Platform

Proprietary oral appliance platform centered on mandibular advancement technology, featuring the Thermal Matrix™ custom-fit design and adjustable mechanisms for treating upper airway obstruction.

Opportunities

The massive and under-penetrated global sleep apnea market, coupled with low CPAP compliance, creates a significant demand for effective alternatives like oral appliances.

Growing consumer awareness of sleep health and the expansion of dental sleep medicine present channels for growth.

The company's FDA-cleared OTC product provides a unique gateway to capture the large consumer snoring market.

Risk Factors

Intense competition from both low-cost generic devices and well-capitalized medical device companies poses a constant threat.

Regulatory changes and insurance reimbursement challenges for oral appliance therapy could limit market access.

Potential side effects from device use, such as dental changes or jaw pain, present clinical and liability risks.

Competitive Landscape

Apnea Sciences competes in the crowded oral appliance therapy market against public companies like SomnoMed and ProSomnus, which offer custom-fit devices through dental channels, as well as numerous direct-to-consumer brands. Its key differentiation is the FDA clearance for OTC use of SnoreRx and positioning ApneaRx as a cost-effective, professional-grade alternative to both CPAP and expensive custom dental lab appliances.

More companies in Digital Health & Biotech SaaS →More companies in United States →